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Abstract:
The ability of stressful life events to trigger drug use is particularly
problematic for the management of cocaine addiction due to the
unpredictable and often uncontrollable nature of stress. For this reason,
understanding the neurobiological processes that contribute to stress-related
drug use is important for the development of new and more effective
treatment strategies aimed at minimizing the role of stress in the addiction
cycle. In this review we discuss the neurocircuitry that has been implicated in
stress-induced drug use with an emphasis on corticotropin releasing factor
actions in the ventral tegmental area (VTA) and an important pathway from
the bed nucleus of the stria terminalis to the VTA that is regulated by
norepinephrine via actions at beta adrenergic receptors. In addition to the
neurobiological mechanisms that underlie stress-induced cocaine seeking, we
review findings suggesting that the ability of stressful stimuli to trigger
cocaine use emerges and intensifies in an intake-dependent manner with
repeated cocaine self-administration. Further, we discuss evidence that the
drug-induced neuroadaptations that are necessary for heightened
susceptibility to stress-induced drug use are reliant on elevated levels of
glucocorticoid hormones at the time of cocaine use. Finally, the potential
ability of stress to function as a “stage setter” for drug use – increasing
sensitivity to cocaine and drug-associated cues – under conditions where it
does not directly trigger cocaine seeking is discussed. As our understanding of
the mechanisms through which stress promotes drug use advances, the hope
is that so too will the available tools for effectively managing addiction,
particularly in cocaine addicts whose drug use is stress-driven.
Keywords: Cocaine, Stress, Relapse, Norepinephrine, CRF, Glucocorticoid,
Review.

1. Stress-related cocaine use: evidence from
human addicts
An accumulating body of evidence suggests that there is a
strong relationship between stress and drug use by cocaine addicts.
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Anecdotal reports suggesting that stressful life events can precipitate
relapse are paralleled by laboratory findings that the presentation of
pre-recorded individualized stress-related scripts can induce craving in
cocaine-dependent individuals (Sinha et al., 1999, 2000) and by
epidemiological studies demonstrating high rates of co-morbidity
between cocaine dependence and a number of stress-related
disorders, including depression, anxiety, and post-traumatic stress
disorder (PTSD; Rounsaville et al., 1991; Chen et al., 2011). In fact, it
is likely that most incidents of relapse in cocaine addicts are in some
way stress-related. In the case of PTSD, morbidity is not only higher in
cocaine-dependent individuals (Cottler et al., 1992), but in many cases
traumatic events predate cocaine use (Brady et al., 1998) and imagery
based on the traumatic episode can elicit drug craving (Coffey et al.,
2002). Indeed, one study noted that 95% of individuals with comorbid PTSD and cocaine dependence reported a functional
relationship between PTSD-related symptoms and drug use, with 86%
reporting that a worsening of symptoms resulted in increased cocaine
use (Back et al., 2006). While it is clear that a relationship exists
between stress and cocaine use, the precise contribution of stress to
the addiction process remains unclear and in many cases likely
involves a complex interaction between stressful stimuli, cocainerelated cues, and the effects of the drug itself and may vary across
different subpopulations of addicts (Preston and Epstein, 2011). These
effects of stress on cocaine use are particularly problematic due to
their unavoidable nature, making stress a key target for interventions
aimed at relapse prevention. Thus, understanding the neurobiological
processes that mediate the influence of stress on cocaine use is
important for devising new and more effective therapeutic approaches
for the management of addiction.

2. Rodent models for studying stress-induced
relapse
The contribution of stress to drug relapse can be studied preclinically using reinstatement-based designs in which the ability of
various stressful stimuli to re-establish extinguished cocaine seeking is
assessed in rats or mice. Despite some concerns about their construct
validity (e.g., extinction of behavior in rodents is not the same as
abstinence in human addicts) and their predictive validity (it is not
clear that these approaches can be used to reliably identify effective
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relapse interventions), these approaches have been critical in shaping
our understanding of the neurobiological pathways that contribute to
stress-related drug use. Brief over-views of the two primary variations
of these approaches, as applied in our laboratory, are provided below.
Representative graphs depicting stress-induced cocaine seeking as
measures using these approaches are shown in Fig. 1.

Fig. 1

Stress-induced cocaine seeking in mouse (A–C) and rat (D–F) models.

Stress-induced reinstatement of extinguished cocaine-induced CPP is shown in Figs. AC. Preference for a cocaine-paired compartment (4 × 15 mg/kg, ip) was established
(A; increase in time spent post-conditioning vs. pre-conditioning) and extinguished (B)
in C57BL/6 mice (n = 4) prior to reinstatement of preference by pre-exposure to a
forced swim session (C; 6-min swim in 22 °C water; *P < 0.05 vs. Bas). Stressinduced reinstatement in rats following cocaine self-administration and extinction is
shown in Figs. D–F. Following training, rats (n = 5) self-administered cocaine (1.0
mg/kg/inf) by pressing a lever during daily 6-h sessions for 14 days (D) prior to
undergoing extinction over a 10-day period during daily 2-h sessions (E) and
reinstatement testing (F). Stress-induced reinstatement was observed as the ability of
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footshock stress (0.5 mA; 0.5” duration delivered an ave. of 40-s apart over a 15-min
session) to increase responding on the cocaine lever (*P < 0.05 vs. Bas).

2.1. Self-administration/reinstatement approaches in
rats
In rats, the study of relapse typically involves testing for the
reinstatement of extinguished responding following intravenous
cocaine self-administration (SA). Although a variety of stressors have
been demonstrated to reinstate cocaine seeking following SA in rats,
including food restriction (Shalev et al., 2003) and forced swim
(Conrad et al., 2010), the most common method involves the use of
uncontrollable intermittent electric footshock delivered through the
grid floors of the SA chambers (Ahmed and Koob, 1997; Erb et al.,
1996). Notably, while a number of laboratories have demonstrated
footshock-induced reinstatement of cocaine seeking following SA in
rats, the conditions under which reliable rein-statement has been
observed are very specific (see e.g., Shelton and Beardsley, 2005)
and, in our hands, depend on a history of SA under conditions of
prolonged daily access (Mantsch et al., 2008a,b).

2.2. Conditioned place preference/reinstatement
approaches in mice
Methodological considerations limit the utility of SA-based
approaches in mice. Instead, relapse is commonly studied in mice by
examining the ability of stressors to re-establish preference for a
cocaine-paired environment following the extinction of cocaine-induced
conditioned place preference (CPP). As is the case with the SA
approach in rats, a number of stressors, including social stress (Ribeiro
Do Couto et al., 2006) and uncontrollable electric footshock (Redila
and Chavkin, 2008), have been demonstrated to reinstate
extinguished drug-induced CPP in mice. However, the most frequently
applied approach, and the one used in our laboratory, involves a brief
(6-min) forced swim at 22 °C prior to transfer to the conditioning
apparatus (Kreibich and Blendy, 2004; Mantsch et al., 2008a,b).
Go to:
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3. Anatomy of stress-induced relapse
3.1. Overview of the neurocircuitry implicated in stressinduced reinstatement
Using the reinstatement approach in rodents, we and others
have begun to define the neurocircuitry involved in stress-induced
cocaine seeking. A putative circuit for stress-induced cocaine use is
included in Fig. 2. Like other reinstating stimuli (e.g., priming
injections of cocaine and cocaine-associated cues; see Kalivas and
McFarland, 2003 for review) stress-induced reinstatement appears to
involve a corticostriatal glutamatergic projection from the prelimbic
cortex to the nucleus accumbens (NAc) core which likely regulates
striato-pallidal outputs to produce drug seeking. Accordingly,
McFarland et al. (2004) demonstrated that inhibition of the NAc core
using a GABA receptor agonist cocktail blocks footshock-induced
reinstatement in rats while several groups have found that dopamine
(DA) D1 receptor antagonism in the medial prefrontal cortex (mPFC)
prevents stress-induced cocaine seeking (Capriles et al., 2003;
Sanchez et al., 2003; McFarland et al., 2004). In the PFC, D1 DA
receptors are expressed on pyramidal cells, including those that
project to the NAc core, where they promote excitability primarily by
increasing NMDA receptor-mediated excitability (Lewis and O’Donnell,
2000; Seamans et al., 2001). However, D1 receptors are also found
on fast-spiking GABAergic interneurons which they inhibit to further
increase pyramidal cell excitability (Gonzalez-Islas and Hablitz, 2001).
The latter mechanism could account for fMRI studies in human addicts
showing that BOLD signal is reduced during stress-induced craving
(Sinha et al., 2005). Dopaminergic projections to the mPFC arise from
the ventral tegmental area (VTA), which appears to be a key
integration site at which inputs that relay stress- and drug
context/cue-related information converge. Brain structures upstream
from this mesocortical pathway that are necessary for stress-induced
relapse appear to include the bed nucleus of the stria terminalis
(BNST), the central nucleus of the amygdala (CeA), and the NAc shell
(McFarland et al., 2004; Briand et al., 2010). Collectively, these
regions are often considered to comprise a larger complex, termed the
extended amygdala, based on their anatomical similarities. Recently, a
number of laboratories, including ours, have begun to explore the
mechanisms within the VTA through which stressors regulate cocaineNeuropharmacology, Vol. 76, No. Part B (January 2014): pg. 383-394. DOI. This article is © Elsevier and permission has
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seeking behavior as well as the potential role of inputs from
components of the extended amygdala – particularly the BNST (Geisler
and Zahm, 2005; Dong and Swanson, 2006) – in promoting drug use
during periods of stress.

Fig. 2

Ongoing areas of research on the mechanisms through which stress promotes

cocaine use. One putative pathway that underlies stress-induced reinstatement is a
key corticotropin releasing factor- (CRF-) releasing pathway from the bed nucleus of
the stria terminalis (BNST) to the ventral tegmental area (VTA) that is regulated by
norepinephrine released from noradrenergic projections primarily from medullary
noradrenergic cells groups and appears to be partly under the control of an input from
the central nucleus of the amygdala (CeA). In the BNST, beta adrenergic receptors
and CeA projections appear to induce cocaine seeking via local release of CRF and
BNST CRF-R1 receptor activation. In the VTA, BNST inputs converge with afferents
from other regions, including the nucleus accumbens (NA) shell and the CeA to
regulate dopamine (DA) release in the prelimbic cortex (PLC). DA in the PLC cortex
promotes excitation of a glutamatergic pathway to the NA core that has been
proposed to function as a common final pathway through which a range of stimuli
induces cocaine seeking. Current areas of research focus in our lab include
investigation of: 1) the CRF-releasing pathway from the BNST to the VTA and its
regulation by beta-2 adrenergic receptors; 2) the mechanisms through which CRF-R1
receptor activation in the VTA regulate DA projections; 3) glucocorticoid-dependent
processes in these regions through which stress can “set the stage” for cocaine use,
including glucocorticoid inhibition of the monoamine transporter, organic cation
transporter 3 (OCT3) and glucocorticoid regulation of endocannabinoid (eCB)
production; and 4) glucocorticoid-dependent neuroplasticity in these pathways that
increases susceptibility to cocaine seeking and contributes to the onset of addiction.
Other abbreviations: glutamate (GLU).
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3.2. A BNST to VTA projection
Although the neuroanatomy of stress-induced cocaine use is
complex and almost certainly involves the coordinated activity of
numerous inputs that converge upon the VTA to integrate emotion-,
context-, and memory-related signals, one pathway that stands out as
a key regulator of drug use is a projection from the BNST to the VTA.
The BNST has long been known to serve as an important site at which
stress-related responses are integrated. Towards this end, the BNST
receives dense innervation from a number of structures involved in
stressor-responsiveness, most notably heavy brainstem noradrenergic
inputs from the locus coeruleus and medullary cell groups (see Smith
and Aston-Jones, 2008 for review) and a prominent projection from
the CeA (Zahm et al., 1999). Indeed, the BNST, through its
projections to the hypothalamus, is a key regulator of the hormonal
stress response (Forray and Gysling, 2004). Additionally, the BNST has
reciprocating connectivity with the VTA from which it receives DA
inputs, thus positioning it as a potential interface between stress and
motivated behavior and therefore as a site at which stressors could
promote drug use. Accordingly, inhibition of the BNST attenuates
stress-induced reinstatement in both rat (McFarland et al., 2004) and
mouse (Briand et al., 2010) models. Recent work from our lab and
others suggests that brainstem adrenergic inputs into the BNST, likely
in coordination with projections from the CeA, regulate a pathway that
ultimately releases the neuropeptide corticotropin-releasing factor
(CRF) into the VTA. A major focus of the current research in our lab
involves understanding the mechanisms through which CRF in the VTA
and norepinephrine (NE) in the BNST promote cocaine seeking.

4. A role for CRF in stress-induced relapse
CRF is a 41 amino acid neuropeptide that plays a key role in
regulating both the hormonal and behavioral responses to stressors.
CRF produces it effects via two receptors, both of which are Gs Gprotein coupled but may also activate other signaling pathways cite
(see Behan et al., 1996 for review): 1) the CRF-R1 receptor, which has
a higher affinity for CRF and has a relatively widespread expression
pattern in the brain and 2) the CRF-R2 receptor, which has a lower
affinity for CRF and a more restricted pattern of expression. Notably,
the CRF-R2 receptor preferentially binds to a family of CRF-related
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peptides, the urocortins, and may interact with CRF more effectively
via a mechanism that also involves the CRF binding protein.

4.1. CRF and stress-induced reinstatement
CRF is a key regulator of stress-induced reinstatement. We and
others have shown that systemic or intra-cerebroventricular (icv)
administration of CRF receptor antagonists prevents footshock-induced
reinstatement in rats (Erb et al., 1998; Shaham et al., 1997; Graf et
al., 2011) while central administration of CRF alone can induce cocaine
seeking (Erb et al., 2006; Mantsch et al., 2008a,b). The role of CRF in
stress-induced reinstatement is independent of its regulation of the
hypothalamice–pituitary–adrenal (HPA) axis. Eliminating the plasma
corticosterone response via surgical adrenalectomy and basal
corticosterone replacement does not attenuate reinstatement by either
footshock (Erb et al., 1998; Graf et al., 2011) or icv CRF
administration (Graf et al., 2011). Although blocking CRF receptors
prevents stressor-induced rein-statement, it has no effect on
reinstatement by a priming injection of cocaine (Erb et al., 1998; Graf
et al., 2011), suggesting that the pathways underlying stress-induced
relapse may be distinct from those that mediate drug use in response
to other triggers.

4.2. Role of CRF in the VTA in stressor-induced
reinstatement
The VTA is a key site for CRF regulation of cocaine seeking. Both
CRF-R1 and CRF-R2 receptors (Goeders et al., 1990; Van Pett et al.,
2000; Korotkova et al., 2006) as well as the CRF binding protein
(Wang and Morales, 2008) are expressed in the VTA which receives
CRF positive projections from several brain regions, including the BNST
(Rodaros et al., 2007). Correspondingly, extracellular CRF levels in the
VTA, as measured using in vivo microdialysis and radioimmunoassay,
are increased during footshock-induced rein-statement in rats (Wang
et al., 2005). We and others have found that delivery of CRF directly
into the VTA is sufficient to reinstate cocaine seeking following SA in
rats, while intra-VTA CRF receptor antagonist administration prevents
footshock-induced reinstatement (Wang et al., 2005, 2007; Blacktop
et al., 2011).
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4.2.1. Role for CRF-R1 receptors
While it is generally agreed that CRF release in the VTA is
required for stress-induced reinstatement, the receptor subtype that
mediates the effects of CRF on cocaine seeking is controversial. Using
the SA/reinstatement approach in rats, we have found that the CRF-R1
but not the CRF-R2 receptor in the VTA is necessary for CRF- and
stress-induced reinstatement, and that activation of the CRF-R1
receptor in the VTA alone is sufficient to reinstate cocaine seeking
(Blacktop et al., 2011). Intra-VTA pretreatment with the CRF-R1
receptor-selective antagonists antalarmin or CP-376395 blocks
reinstatement in response to delivery of CRF into the VTA or footshock
without producing response-limiting sedative effects, while intra-VTA
pretreatment with the CRF-R2 receptor-selective antagonist
astressin2B has no effect. Similarly the reinstating effects of footshock
and intra-VTA CRF are reproduced by administration of the CRF-R1
receptor-selective agonist, cortagine, into the VTA but not the CRF-R2
receptor-selective agonist, rat urocortin 2. These findings are
consistent with reports that systemic administration of antalarmin also
blocks stress-induced reinstatement of cocaine seeking in rats
(Shaham et al., 1998) or mice (our own unpublished data) as well as
stress-induced reinstatement following heroin (Shaham et al., 1997),
alcohol (Lê et al., 2000), and nicotine (Bruijnzeel et al., 2009) SA.

4.2.2. Role for CRF-R2 receptors
A role for the CRF-R2 receptor in stress-induced relapse has also
been reported (Wang et al., 2005, 2007). In these studies, which
involved more prolonged delivery into the VTA via reverse microdialysis, it was found that reinstatement by footshock or intra-VTA CRF
delivery was blocked by antagonists at CRF-R2 but not CRF-R1
receptors. The mechanism of action in these studies appeared to
involve CRF interactions with the CRF binding protein. Agents that
displace CRF from its binding protein prevented reinstatement and the
corresponding neurochemical changes in the VTA while only CRF-R2
agonists that also interact with the binding protein induced cocaine
seeking (Wang et al., 2007). Notably, this finding is consistent with a
report that CRF can potentiate NMDA receptor mediated synaptic
transmission in the VTA through a similar mechanism (Ungless et al.,
2003). Differences in the mode and duration of CRF/antagonist
delivery, as well as the experimental history of the rats likely
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contributed to the disparate findings regarding the role of CRF receptor
subtypes in stress-induced cocaine seeking. Nonetheless, the
implication of both receptors is not particularly surprising, considering
the VTA expression profile of CRF receptors (both subtypes are
expressed on DA and non-DA cells and likely on nerve terminals) as
well as the complexity of CRF actions in the VTA.

4.3. CRF actions in the VTA
CRF has been reported to produce both excitatory (Wanat et al.,
2008; Korotkova et al., 2006) and inhibitory (Beckstead et al., 2009)
effects on DA neuronal activity in the VTA, to alter synaptic integration
via intracellular calcium mobilization in DA cells (Riegel and Williams,
2008), and to promote excitatory synaptic transmission through postsynaptic trafficking of NMDA and AMPA receptors (Ungless et al.,
2003; Hahn et al., 2009). Additionally, CRF promotes glutamate
release in the VTA as measured using in vivo microdialysis (Wang et
al., 2005), a finding that is consistent with reports that CRF also
increases the frequency of AMPAR-mediated spontaneous miniature
EPSCs in DA cells in slice preparations (Hahn et al., 2009). Based on
its effects on excitatory neurotransmission, it has been proposed that
the primary function of CRF in the VTA during stress is to excite DA
cells, thereby activating mesocorticolimbic neurotransmission and
promoting drug use (Wise and Morales, 2010). Consistent with this
hypothesis, CRF delivery into the VTA increases local DA release
measured during reinstatement testing (Wang et al., 2005), while
glutamate receptor antagonism in the VTA prevents both increases in
local DA levels and stressor- and CRF-induced reinstatement (Wang et
al., 2005). However, with the exception of a small group of DA cells in
the most ventral aspects of the VTA (Brischoux et al., 2009), the timelocked response of DA cells in the VTA to stressful/aversive stimuli in
the absence of drug-associated context is a reduction in firing rate
(Ungless et al., 2004, 2010). Likewise, the time-locked DA response in
the NAc to such stimuli, as measured using voltammetry, is also a
decrease (Badrinarayan et al., 2012; Roitman et al., 2008; Oleson et
al., 2012). Taken together, these findings suggest that the mesolimbic
DA response to stressful/aversive stimuli is somewhat incompatible
with a model that assumes that increased CRF release into the VTA will
evoke drug seeking simply by exciting dopaminergic efferents.
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It is intriguing to speculate that, rather than producing direct
excitatory effects in the VTA, CRF serves as a coordinator of VTA
function – generally silencing DA cellular activity in the absence of
drug-associated stimuli, while opportunistically promoting signaling via
key excitatory inputs that relay drug-related/appetitive information to
the VTA. Consistent with this possibility, it has been reported that CRF
receptor antagonism increases DA neuron population activity in the
VTA but attenuates evoked DA release in the NAc (Lodge and Grace,
2005). This coordinating function of CRF in the VTA could position it as
a key determinant of stimulus salience and coping behaviors during
periods of stress and may have implications not only for addiction but
also for under-standing other conditions associated with aberrant
stress-related behavioral responses.
Adding to the difficulty in understanding CRF function in the VTA
is the anatomical complexity of the region. While often studied as a
uniform structure in terms of cellular composition and connectivity, the
VTA is comprised of both DA and non-DA (i.e., local and projecting
GABAergic and glutamatergic) cell types (Steffensen et al., 1998; Dobi
et al., 2010; Yamaguchi et al., 2011) that are differentially regulated
during periods of stress depending on their anatomical localization, the
neurochemical context at the time of stimulation and differences in
their intrinsic properties that may render them differentially responsive
to the same input. The potential significance of this differential
responsiveness to motivated behavior is evident when considering that
the putative pathway responsible for stress-induced cocaine seeking
involves reciprocating connectivity between the VTA and the BNST and
NAc shell that ultimately regulates the activity of a key DA projection
from the VTA to the mPFC (McFarland et al., 2004). Therefore, the
possibility that CRF differentially regulates distinct neuronal subpopulations in the VTA, possibly in a receptor subtype-dependent
manner, cannot be ruled out. Indeed, CRF-R1 receptors are
heterogeneously expressed on multiple cell types in the VTA
(Korotkova et al., 2006; Refojo et al., 2011) and the behavioral
consequences of CRFR-1 receptor deletion these different cell types
(GABAergic vs. glutamatergic vs. dopaminergic) varies significantly
(Refojo et al., 2011).
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4.4. CRF-releasing projections to the VTA
The sources of CRF release into the VTA appear to include
projections that originate from several regions known to be critical
regulators of stress-related hormonal and behavioral responses,
including the CeA, the paraventricular nucleus of the hypothalamus,
and BNST (Rodaros et al., 2007). CRF-containing projections to the
VTA appear to be both glutamatergic and GABAergic, suggesting that
co-released CRF can participate in both excitatory and inhibitory
transmission (Tagliaferro and Morales, 2008). However, most of the
direct innervation of tyrosine hydroxylase-positive cells appears to be
glutamatergic (Tagliaferro and Morales, 2008). The nature of the
connectivity with other VTA cell types has not been determined. In
light of studies demonstrating that the BNST is critical for stressinduced cocaine seeking (McFarland et al., 2004; Briand et al., 2010),
we have recently begun to examine the importance of this CRFreleasing BNST to VTA projection in stress-induced relapse and its
regulation by noradrenergic neurotransmission. Importantly, while
much research, including our own, has focused on the involvement of
the BNST-to-VTA pathway, CRF-releasing projections from other
regions likely also contribute to relapse. For example, it has been
reported that inhibition of the CeA prevents stress-induced cocaine
seeking (McFarland et al., 2004). It is tempting to speculate that the
release of CRF into the VTA from multiple pathways and its actions on
functionally distinct sub-populations of cells in the VTA account for the
complicated and often seemingly contradicting literature describing
CRF’s actions in the region.

5. Norepinephrine
Central noradrenergic signaling has been implicated in a number
of stress-related processes, including stress-induced relapse. Key
sources of central noradrenergic projections include the locus
coeruleus (A6 region) and groups of nuclei in the pons and rostral
medulla (A1, A2, A5, and A7) whose projections collectively comprise
the ventral noradrenergic bundle (VNAB). Adrenergic receptors bound
by centrally released NE are primarily G-protein coupled and include
Gs-coupled beta-1, beta-2 and beta-3 adrenergic receptors, Gq-coupled
alpha-1 adrenergic receptors, and Gi-coupled alpha-2 adrenergic
receptors. Noradrenergic innervation and adrenergic receptor
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expression in the CNS is widespread and includes a number of regions
implicated in stress-induce cocaine seeking, including the NA shell,
mPFC, and the BNST (Berridge, 2008).

5.1. NE and stress-induced relapse
An important role for noradrenergic signaling in stress-induced
relapse has been established. We and others have shown that
functional antagonism of noradrenergic signaling via administration of
alpha-2 adrenergic receptor agonists such as clonidine prevents
footshock-induced reinstatement in rats (Erb et al., 2000) and swiminduced reinstatement in mice (Mantsch et al., 2010). Conversely, the
activation of central noradrenergic neurotransmission through alpha-2
adrenergic autoreceptor antagonism by drugs such as yohimbine is
sufficient to reinstate cocaine seeking in rats (Feltenstein and See,
2006; Brown et al., 2009), monkeys (Lee et al., 2004) or mice
(Mantsch et al., 2010; Vranjkovic et al., 2012). These reinstating
effects can be reproduced by central (icv) administration of NE in rats
(Brown et al., 2011). Like CRF, the role of NE in reinstatement appears
to be specific to stress, as alpha-2 adrenergic receptor agonists fail to
attenuate cocaine-primed reinstatement in rats or mice (Erb et al.,
2000; Mantsch et al., 2010). The potential utility of targeting
noradrenergic neurotransmission for managing stress-induced relapse
in cocaine addicts is supported by findings that alpha-2 adrenergic
receptor agonists prevent stress-induced craving in human cocainedependent subjects (Jobes et al., 2011; Fox et al., 2012).

5.2. Role of adrenergic receptors in stress-induced
reinstatement
Using the mouse CPP/reinstatement approach, we have
identified an important role for beta, but not alpha-1 adrenergic
receptors in stress-induced relapse. Reinstatement following forced
swim or yohimbine administration is prevented by pretreatment with
the beta adrenergic receptor antagonist, propranolol, but not by the
alpha-1 adrenergic receptor antagonist, prazosin (Mantsch et al.,
2010) and is reproduced by administration of the beta adrenergic
receptor agonist, isoproterenol (Vranjkovic et al., 2012). Furthermore,
forced swim fails to produce reinstatement in beta adrenergic
receptor-deficient mice (Vranjkovic et al., 2012). More specifically,
stress-induced reinstatement appears to require the beta-2 but not the
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beta-1 adrenergic receptor. Reinstatement following forced swim or
alpha-2 receptor antagonism is blocked by pretreatment with the beta2 adrenergic receptor-selective antagonist, ICI-188,551, but not the
beta-1 adrenergic receptor-selective antagonist betaxolol, while
administration of the beta-2 adrenergic receptor-selective agonist,
clenbuterol, is sufficient to reinstate (Vranjkovic et al., 2012). In situ
hybridization and auto-radiography studies have demonstrated that
beta-2 adrenergic receptors are expressed in a number of brain
structures that have been implicated in stress-induced relapse,
including the PFC and structures that comprise the extended amygdala
complex (Asanuma et al., 1991; Rainbow et al., 1984). However, the
finding that beta adrenergic receptor blockade in the BNST using a
cocktail of beta-1 and beta-2 receptor antagonists prevents footshockinduced reinstatement in rats (Leri et al., 2002) has led to the
hypothesis that beta-2 adrenergic receptor activation of a CRFreleasing projection from the BNST to the VTA is critical for stressinduced cocaine use.

5.3. BNST connectivity with the VTA
As described above (Section 3.2), the BNST is required for
stress-induced reinstatement of extinguished cocaine seeking following
SA in rats (McFarland et al., 2004) and CPP in mice (Briand et al.,
2010) and sends projections to the VTA that co-release CRF (Rodaros
et al., 2007). Both glutamatergic and GABAergic projections from the
BNST to the VTA have been characterized (Georges and Aston-Jones,
2002; Kudo et al., 2012; Jennings et al., 2013) and a recent
disconnection study showing attenuated expression of CPP following
contralateral inhibition of the BNST in one hemisphere and VTA of the
other supports a functional role for this pathway in cocaine seeking
(Sartor and Aston-Jones, 2012). Recent work by Stuber and colleagues
(Jennings et al., 2013), has provided a more comprehensive picture of
the anatomy and function of BNST projections to the VTA. Both
glutamatergic and GABAergic projections to the VTA are activated
during stress but exert functionally divergent regulation of stressrelated behaviors. Notably, both circuits primarily innervate non-DA
cells in the VTA and most of the direct innervation of DA cells appears
to be GABAergic (Jennings et al., 2013). It has not yet been
determined which of the projections from the BNST co-releases CRF,
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nor has the relative contribution of these distinct pathways to stressinduced cocaine seeking.

5.4. Noradrenergic neurotransmission in the BNST and
stress-induced relapse
The BNST receives dense noradrenergic innervation, much of
which consists of projections from medullary cell groups conducted as
part of the VNAB (Shin et al., 2008). Indeed, it has been reported that
disruption of the locus coeruleus fails to attenuate stress-induced drug
seeking following opiate SA or opiate-induced CPP, while lesion of the
VNAB or inhibition of more caudal adrenergic cell groups prevents
stress-induced reinstatement (Shaham et al., 2000; Wang et al.,
2001). Both alpha and beta adrenergic receptor subtypes are
expressed in the BNST (Rainbow et al., 1984; Asanuma et al., 1991;
Day et al., 1997; Shields et al., 2009). However, it has been found
that beta adrenergic receptors in the BNST are particularly important
for stress-induced cocaine seeking. Leri et al. (2002) reported that
administration of a cocktail consisting of betaxolol and ICI-118,551
into the BNST dose-dependently attenuated footshock-induced
reinstatement in rats. We have reproduced these findings with
administration of ICI-118,551 into the BNST by itself (unpublished
findings), suggesting that beta-2 adrenergic receptor activation in the
BNST is necessary for stress-induced relapse. In the BNST, beta
adrenergic facilitation of both GABAergic (Dumont and Williams, 2004)
and glutamatergic (Egli et al., 2005; Nobis et al., 2011 regulation of
neuronal function has been reported. Recently, we have provided more
direct evidence for a beta-2 adrenergic receptor-regulated, CRFreleasing pathway from the BNST to the VTA; ICI-118,551
administration in the BNST of one hemisphere and contralateral CRFR1 receptor antagonism using antalarmin in the VTA of the other
hemisphere prevents footshock-induced reinstatement (unpublished
data). Altogether, these findings establish the likely importance of a
beta-2 adrenergic regulated CRF-releasing pathway to the VTA for
stress-induced cocaine use.

5.5. NE regulation of CRF in the BNST
Although the exact mechanism through which beta adrenergic
receptors regulate projections from the BNST to the VTA has not been
fully characterized, recent evidence suggests that it likely involves
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effects on CRF release into the BNST and the resulting activation of
CRF-R1 receptors. Like the VTA, CRF-R1 receptor activation in the
BNST is necessary for stress-induced reinstatement (Erb and Stewart,
1999). The source of CRF in the BNST is unclear and may involve
release from terminals of neurons that project into the region
(Beckerman et al., 2013) or from local cell populations (Silberman et
al., 2013). The BNST receives a strong projection from the CeA (Zahm
et al., 1999) and this projection appears to be required for stressinduced reinstatement, since inhibition of the CeA–BNST pathway via
TTX administration in the CeA in one hemisphere and contralateral CRF
receptor antagonism in the BNST of the other hemisphere prevents
footshock-induced reinstatement (Erb et al., 2001). In the BNST, CRF
facilitates excitatory regulation of efferent projections (Kash et al.,
2008; Nobis et al., 2011), including those that innervate the VTA
(Silberman et al., 2013), likely via activation of CRF-R1 receptors on
glutamatergic terminals (Silberman et al., 2013). We hypothesize that,
ultimately, these beta-2 adrenergic receptor-regulated processes in
the BNST increase the activity of CRF-releasing projections to the VTA.
Although this hypothesis has not been directly tested, it has been
found that icv administration of a CRF receptor antagonist blocks
reinstatement by central NE delivery, while functional antagonism of
noradrenergic neurotransmission via clonidine fails to affect
reinstatement following icv administration of CRF (Brown et al., 2009).

6. Intake-dependent emergence of stress-induced
reinstatement
The contribution of stress to drug use is not uniform across all
cocaine users and appears to vary significantly based on a number of
factors, including the context within which stress is encountered,
genetic predisposition, and, importantly, the history of prior cocaine
use. For example, it has been reported that a prior history of higher
frequency cocaine use is associated with augmented stress-induced
craving measured in a laboratory setting in cocaine-dependent
individuals (Fox et al., 2005). A possible explanation for the
relationship between heightened sensitivity to stress-induced craving
and previous drug use is that repeated drug exposure establishes
intake-dependent neuroplasticity that renders addicts more susceptible
to stressor-induced cocaine seeking.
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6.1. Long-access cocaine SA
One approach that can be used to investigate persistent druginduced neuroplasticity related to heightened use involves the study of
rats provided chronic daily prolonged access to cocaine for SA (Ahmed
and Koob, 1998). Using this approach, Koob and colleagues have
demonstrated that, over time, rats self-administering under these
conditions display an escalating pattern of cocaine intake that is
associated with and likely the consequence of the emergence of an
anhedonic/dysphoric state attributable to the recruitment of a number
of opponent process mediators, including dynorphin/kappa opioid (Wee
et al., 2009), endocannabinoid (Orio et al., 2009), noradrenergic (Wee
et al., 2008), and CRF (Specio et al., 2008) systems (see Koob, 2009
for review). We and others have found that the consequences of
extended-access SA are long-lasting and affect cocaine-seeking in
relapse models, as demon-strated by heightened susceptibility to
reinstatement in response to cocaine priming (Mantsch et al., 2004),
presentation of cocaine-associated cues (Kippin et al., 2006), and
stress (Mantsch et al., 2008a).

6.2. Establishment of stress-induced reinstatement
following long-access SA
Research in our laboratory has focused on how SA history alters
subsequent susceptibility to stress-induced reinstatement. We have
found that increasing the amount of prior cocaine SA by allowing rats
to self-administer cocaine under long-access conditions (14 × 6 h/day)
that result in very high levels of daily drug intake (approximately 70
mg/kg/day) augments the ability of electric footshock to reinstate
cocaine seeking (Mantsch et al., 2008a). Indeed, under the SA and
shock conditions that we use, robust and reliable reinstatement of
extinguished cocaine seeking in response to electric footshock, only
occurs when rats have a history of SA under long-access conditions
and is not observed in rats with history of SA under conditions of more
limited access (14 × 2 h/day; approximately 15 mg/kg daily intake;
Mantsch et al., 2008a). Others have reported shock-induced
reinstatement of cocaine seeking in the absence of prior testing under
long-access SA conditions (e.g., Ahmed and Koob, 1997; McFarland et
al., 2004). However, since susceptibility to reinstatement is likely also
determined by environmental variables (e.g., food restriction, time of
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day, handling, and experimental context) and genetic factors (e.g., rat
strain), we do not view our findings as disparate, especially
considering that we have optimized our approach to study the ability
of SA history to influence later cocaine seeking as measured using the
reinstatement approach. Notably, other groups have similarly reported
that footshock does not reliably induce rein-statement after shortaccess cocaine SA (e.g., Shelton and Beardsley, 2005).

6.2.1. Neuroadaptations that underlie heightened susceptibility
to stress-induced relapse
Recognizing that the ability of stressors to trigger relapse is
likely influenced by intake-dependent cocaine-induced neuroplasticity,
we have begun to search for neuroadaptations in the pathways that
underlie stress-induced cocaine seeking that are associated with longaccess cocaine SA. Not surprisingly, repeated cocaine exposure has
been found to produce widespread alterations in synaptic strength,
structure, and regulation, many of which have the potential to
influence stress-induced reinstatement and emerge in an intakedependent manner with cocaine SA (see Koob and Volkow, 2010 for
review). A complete inventory of all of these adaptations is well
beyond the scope of this review. Instead, here we will briefly
summarize recent findings suggesting that increased responsiveness of
CRF-regulated processes may contribute to heightened relapse
susceptibility.

6.2.2. Augmented CRF responsiveness in the VTA
Our laboratory has demonstrated that, like stress, the ability of
intra-VTA CRF administration to reinstate cocaine seeking emerges
with repeated long-access SA (Blacktop et al., 2011). Bilateral delivery
of CRF directly into the VTA fails to induce reinstatement in rats with a
history of short-access SA (2 h/day) but produces robust
reinstatement when rats have a history of SA under long-access
conditions (6 h/day), suggesting that at least some of the
neuroadaptations responsible for establishing stress as a trigger for
drug use involve processes downstream from the site of CRF action in
the VTA. These findings are consistent with a report that CRF-R1
receptor antagonism only interferes with cocaine SA following repeated
testing under-extended access conditions (Specio et al., 2008). We
hypothesize that alterations in CRF receptor and/or signaling
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mechanisms in the VTA contribute to the heightened CRF
responsiveness. However, since long-access cocaine SA also heightens
cocaine-primed reinstatement – a process that is independent of CRF
(Erb et al., 1998; Graf et al., 2011) - it is clear that at least some of
the contributing neuroplasticity occurs in brain regions downstream
from CRF receptors in the VTA, likely in the cortico-accumbens
pathway required for both stress and drug-induced cocaine seeking
(i.e., in the prelimbic cortex and/or NAc core). Additionally, as the NAc
shell and BNST have reciprocating connectivity with the VTA that may
also be regulated by CRF, adaptations in these regions cannot be ruled
out.

6.2.3. Potential cocaine-induced neuroadaptations in the VTA
In the VTA, repeated cocaine administration has been reported
to increase CRF receptor binding (Goeders et al., 1990) and to alter
CRF responsiveness. For example, it has been demonstrated that
repeated cocaine establishes CRF-R1 receptor-mediate regulation of
glutamatergic synaptic transmission in the VTA (Hahn et al., 2009)
and attenuates CRF-R1 receptor-induced enhancement of GIRK
channel-mediated inhibitory post-synaptic currents (Beckstead et al.,
2009). Likewise, a prior history of cocaine SA is required for CRF
regulation of extracellular DA and glutamate release in the VTA (Wang
et al., 2005). Interestingly, in this study it was also found that, while
CRF responsiveness in the VTA was increased by prior SA, stressinduced CRF release into the VTA was unchanged (Wang et al., 2005).
Thus, cocaine-induced neuroplasticity that contributes to relapse may
involve changes in VTA CRF receptors and/or downstream processes
but not mechanisms (such as those in the BNST) that regulate intraVTA CRF release. Importantly, while all of these changes may
contribute to the heightened stress-induced cocaine seeking observed
following long-access SA, effects of SA under these conditions on CRF
receptor expression, function and downstream signaling have not yet
been reported.

6.3. Induction of neuroplasticity that contributes to
stress-induced relapse
In addition to identifying the neuroplastic changes that underlie
heightened susceptibility to stress-induced relapse, our laboratory has
focused on understanding the neurobiological processes through which
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these changes are put in place. Much of our research has examined
the role of glucocorticoids as potential mediators of addiction-related
neuroplasticity.

6.3.1. Glucocorticoids and relapse-related neuroplasticity
Glucocorticoids secreted as a consequence of activation of the
stressor-responsive HPA axis play a critical role in physiological
processes that enable organisms to effectively adapt to and cope with
stressors (de Kloet et al., 2008; McEwen, 2008). Although elevated
glucocorticoids are of short-term benefit to an organism, prolonged
and/or repeated elevations of glucocorticoids as a result of chronic
stress are maladaptive and lead to a number of pathological
conditions, some of which may contribute to addiction. For example,
we have demonstrated that daily exposure to a stressor, intermittent
footshock, at the time of SA testing produces a progressive escalation
of cocaine SA that is dependent on elevated glucocorticoids (Mantsch
and Katz, 2007).

6.3.2. Effects of cocaine use on glucocorticoids
Like stressors, self-administered cocaine increases
glucocorticoid secretion in rats (Galici et al., 2000), monkeys
(Broadbear et al., 1999), and human cocaine addicts (Ward et al.,
1999). When rats self-administer cocaine during prolonged sessions,
increases in plasma corticosterone are greater and more persistent
than they are with short-access SA (Mantsch et al., 2003) and
physiological signs of increased glucocorticoid secretion (e.g.,
reductions in thymus weight and adrenal hypertrophy) are
exaggerated. Thus, any contribution of elevated glucocorticoids to
cocaine-induced neuroplasticity will likely be particularly pronounced in
rats self-administering cocaine under conditions of prolonged daily
drug access.

6.3.3. Role of elevated glucocorticoids during cocaine use in the
induction of relapse-related plasticity
To examine the potential contribution of elevated glucocorticoids
to the increased susceptibility to later stress-induced rein-statement
that emerges with excessive cocaine use, we eliminated the
glucocorticoid response to cocaine through surgical adrenal-ectomy
along with basal corticosterone replacement before allowing rats to
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self-administer for 14 days under long-access conditions and
subsequently testing for stress and CRF-induced reinstatement (Graf
et al., 2011). While eliminating the adrenal response to cocaine SA
had only very modest effects on cocaine intake and extinction,
subsequent reinstatement in response to footshock or icv CRF delivery
was completely abolished. By contrast, when rats underwent
adrenalectomy following repeated SA but prior to reinstatement
testing (i.e., after cocaine-dependent neuroplasticity was put in place),
footshock- or CRF-induced cocaine seeking was unaffected, suggesting
that elevated glucocorticoids at the time of cocaine use are critical for
establishing neuroadaptations that render addicts susceptible to
stress-induced relapse. Although elevated glucocorticoids appear to be
necessary for the effects of long-access cocaine SA, increasing
glucocorticoids alone during SA does not appear to be sufficient for the
establishment of relapse vulnerability, as daily administration of
corticosterone to adrenalectomized rats at doses that reproduce the
increases plasma levels observed during long-access SA fails to restore
later reinstatement (Mantsch et al., 2008b). This finding is consistent
with our earlier report that elevated corticosterone is necessary but
not sufficient for the effects of repeated stress on cocaine seeking
(Mantsch and Katz, 2007). Notably, the inability of corticosterone
alone to restore reinstatement in adrenalectomized rats suggests that,
during long-access SA, corticosterone may be working in concert with
another adrenal hormone to establish relapse susceptibility e a finding
that is consistent with reports that cocaine-induced behavioral
sensitization requires drug-induced increases in both corticosterone
and epinephrine (de Jong et al., 2009). The potential interaction
between glucocorticoids and other hormones/processes that are
elevated/active during cocaine long-access SA requires further
investigation.

6.3.4. Potential mechanisms underlying glucocorticoiddependent cocaine-induced neuroplasticity
Glucocorticoids produce both glucocorticoid receptor (GR)
mediated genomic effects via transcriptional regulation (de Kloet et al.,
2008) and rapid non-genomic effects mediated via a number of
mechanisms including actions at a putative membrane-associated Gprotein-coupled receptors that can regulate endocannabinoid
production (Tasker et al., 2006) and inhibition of the glucocorticoid
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sensitive monoamine transporter, organic cation transporter 3 (Gasser
et al., 2006). To date, most studies have examined the potential role
of GRs in the establishment of cocaine addiction-related
neuroplasticity. GRs are expressed throughout the neurocircuitry
implicated in stress-induced cocaine seeking, including in CRFexpressing cells in the BNST (Cintra et al., 1987), DA cells in the VTA
(Harfstrand et al., 1986), stress responsive cells in the mPFC
(Ostrander et al., 2003), and a variety of cell types in the NAc (Zoli et
al., 1990). In these regions, GR regulation of key stress-responsive
processes has been demonstrated, including CRF mRNA expression in
the BNST (Schulkin et al., 1998), glutamatergic responsiveness of DA
cells in the VTA (Saal et al., 2003), dendritic morphology (Wellman,
2001) and dopaminergic signaling (Butts et al., 2011) in the mPFC,
and glutamatergic neurotransmission in the NAc (Campioni et al.,
2009). Thus, GRs are well positioned as potential mediators of
glucocorticoid-dependent neuroplasticity that establishes stressinduced cocaine seeking. Although the role of GRs in the effects of
long-access cocaine SA on stress-induced reinstatement has not been
examined, their role in establishing behavioral sensitization and the
reinforcing effects of cocaine has. Constitutive knockout of GRs
prevents cocaine-induced behavioral sensitization and attenuates the
reinforcing effects of cocaine (Deroche-Gamonet et al., 2003), while
forebrain GR overexpression produces the opposite effect (Wei et al.,
2004). One key site of GR mediation of cocaine-induced effects is in
DA receptive neurons in the NA. Selective deletion of GRs in these cells
attenuates cocaine SA (Ambroggi et al., 2009) as well as cocaineinduced behavioral sensitization and CPP (Barik et al., 2010). Future
studies will be required to determine if GR antagonism during longaccess cocaine SA can prevent the effects on subsequent stressinduced reinstatement.

7. “Stage setting” effects of stress for drug
relapse
Our findings that the ability of stressors to reinstate cocaine
seeking is only observed when rats have a history of long-access
cocaine SA (Mantsch et al., 2008a) seem to indicate that stresstriggered relapse may only occur in cocaine addicts with a pro-longed
history of excessive drug use. This should not be misinterpreted to
imply that stressful life events only contribute to relapse in the most
Neuropharmacology, Vol. 76, No. Part B (January 2014): pg. 383-394. DOI. This article is © Elsevier and permission has
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

23

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

extreme addicts. In fact, in many individuals, the role of stress in their
drug use is more subtle and, rather than simply functioning as a
trigger for drug use, appears to involve a more complex interaction
between stress and drug-associated cues and/or cocaine itself.
Accordingly, there are some reports in cocaine-dependent individuals
that stress imagery alone is insufficient to directly elicit drug craving
(De La Garza et al., 2009) and that stressors, such as memories of
traumatic events (Coffey et al., 2002) or exposure to painful stimuli
(Duncan et al., 2007), function by increasing reactivity to drug-related
cues rather than directly evoking craving on their own. This “stage
setting” effect of stress is consistent with findings in rats
demonstrating that stress-induced reinstatement of cocaine-seeking
behavior requires the presence of cues previously associated with
cocaine availability (Shelton and Beardsley, 2005) and that acute
stressors increase the magnitude of reinstatement triggered by
cocaine-associated cues (Feltenstein and See, 2006; Buffalari and See,
2009) or by administration of a dose of cocaine that by itself is
insufficient to reinstate (Graf et al., 2013).
Recently, we have reported that the “stage-setting” effects of
stress are prevented by surgical adrenalectomy and reproduced by
administration of corticosterone at a dose that establishes plasma
levels in the stress-induced range (Fig. 3; Graf et al., 2013). Thus,
glucocorticoids are both sufficient and necessary for the stress-induced
potentiation of cocaine-induced reinstatement. It appears that
corticosterone augments reinstatement by direct actions in the nucleus
accumbens that result in potentiation of the dopamine response to
cocaine via a rapid, GR-independent inhibition of dopamine clearance
that does not involve the dopamine transporter (DAT; Graf et al.,
2013). Glucocorticoids have long been known to acutely block the
clearance of monoamines via uptake2, a high-capacity transport
system first characterized in peripheral tissues (Iversen and Salt,
1970). More recently uptake2 has been attributed to a collection of
transporters that includes the organic cation transporters (OCTs 1, 2
and 3) and the plasma membrane monoamine transporter (PMAT).
Each of these transporters is capable of transporting DA, albeit with
varying efficiency (Duan and Wang, 2010; Gorboulev et al., 2005;
Gründemann et al., 1998) and most are expressed in the brain
(Amphoux et al., 2006; Engel et al., 2004; Vialou et al., 2008; Gasser
et al., 2009). However, only one of these transporters, OCT3, is
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blocked by physiological, stress-induced corticosterone concentrations
(Gasser et al., 2006). We have demonstrated that OCT3 is expressed
on DA D1 receptor-expressing medium spiny neurons in the nucleus
accumbens in close proximity to tyrosine hydroxylase positive nerve
terminals (Gasser et al., 2009; Graf et al., 2013) and that
administration of corticosterone or the non-glucocorticoid inhibitor of
OCT3, nor-metanephrine, directly into the nucleus accumbens
increases cocaine responsiveness via a mechanism that requires DA
receptor activation (Graf et al., 2013).

Fig. 3

Stress-induced potentiation of cocaine-primed drug seeking behavior is

corticosterone-dependent, but does not require GR activation. Reproduced from Graf
et al. (2013) with permission from the Journal of Neuroscience. (A, B) Cocaine lever
responses on the last day of extinction and during reinstatement testing of (A)

Neuropharmacology, Vol. 76, No. Part B (January 2014): pg. 383-394. DOI. This article is © Elsevier and permission has
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

25

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

adrenal-intact or (B) adrenalectomized rats. On the day of reinstatement testing, rats
were subjected to 15 min of uncontrollable, intermittent electric footshock (EFS) or no
shock, followed by injection of cocaine (2.5 mg/kg ip) or saline, and cocaine lever
responses were recorded for 2 h. (C) Acute corticosterone injection mimics stressinduced potentiation of reinstatement. Rats received an injection of corticosterone
(CORT; 2.0 mg/kg ip) or vehicle followed, 40 min later, by an injection of cocaine (2.5
mg/kg ip) or saline. (d) RU38486 pretreatment has no effect on corticosteroneinduced potentiation of reinstatement. Rats received an injection of the GR antagonist
RU38486 (12.5 mg/kg sc) or vehicle, followed 60 min later by injection of
corticosterone (2.0 mg/kg ip) or vehicle, followed 40 min thereafter by an injection of
cocaine (2.5 mg/kg ip). *indicates significantly different from extinction responding (P
< 0.05). Error bars represent mean ± s.e.m.

While these data point to corticosterone-mediated regulation of
dopamine clearance as a key mechanism through which stress can “set
the stage” for cocaine use, other corticosterone-dependent
mechanisms may also be involved. Current areas of investigation
include corticosterone-induced increases in endocannabinoid
production and resulting alterations in the excitability of the corticoaccumbens glutamatergic pathway that mediates cocaine seeking. To
date, our preliminary findings have revealed important roles
endocannabinoids in these “stage setting” effects in part via actions in
the prelimbic cortex. Interestingly, neither glucocorti-coids (Erb et al.,
1998; Graf et al., 2011) nor endocannabinoids (De Vries et al., 2001)
appear to be required for reinstatement by stress alone, suggesting
that the mechanisms for the relapse-triggering and promoting effects
of stress may be non-overlapping.

8. Summary and treatment implications
In summary, recent research in our laboratory has advanced our
understanding of the neurobiological processes through which stressful
stimuli contribute to cocaine use. A schematic depicting some of these
mechanisms is shown in Fig. 2. It is our hope that, from this better
understanding, new and more effective interventions for the
management of cocaine addiction will arise. Indeed, currently available
medications and new drugs in development targeting adrenergic, CRF,
glucocorticoid and cannabinoid receptors as well as cognitive
behavioral approaches focused on stress management may represent
powerful tools through which the contribution of stress to the addiction
process can be minimized, at least in the case of cocaine. Notably,
although the mechanisms through which stress influences drug use
may vary with the class of abused drug, many of the processes likely
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also contribute to stress-related use of a number of drugs, including
opiates, alcohol, and nicotine. For example, it has been reported that
stress-induced reinstatement of drug seeking following heroin
(Shaham et al., 1997), alcohol (Lê et al., 2000) or nicotine (Bruijnzeel
et al., 2009) SA involves CRF, as does stress-induced reinstatement of
palatable food-seeking behavior (Ghitza et al., 2006). Confirmation of
the relevance of the pathways and pathways described in this review
to stress-induced relapse of use of these other drugs awaits more
detailed investigation. Although the contribution of stress to drug use
likely varies across individual addicts, we are optimistic that advances
in the diagnosis of addiction that will permit the identification of
individuals whose drug use is stress-related, along with the availability
of effective stress-targeting therapeutics approaches, will lead to
better treatment outcomes and improve lives.
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